Allopath Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 552.88%
- Profit Growth 217.98%
- Ebitda 233.26%
- Net Worth 86.29%
- Total Assets 382.02%
About Allopath Pharmaceuticals India
Allopath Pharmaceuticals India Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 2019 (Five years and seven months 24 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dheeraj Katyal and Darshana Katyal serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239HR2019PTC081328
- Company No.
081328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Allopath Pharmaceuticals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeraj Katyal  | Director | 05-Jul-2019 | Current |
| Darshana Katyal | Director | 05-Jul-2019 | Current |
Financial Performance of Allopath Pharmaceuticals India.
Allopath Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 552.88% increase. The company also saw a substantial improvement in profitability, with a 217.98% increase in profit. The company's net worth Soared by an impressive increase of 86.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allopath Pharmaceuticals India?
In 2022, Allopath Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neerpath Healthcare Private LimitedDheeraj Katyal is a mutual person
- Urban Hospitality Solutions India Private Limited
Dheeraj Katyal is a mutual person
- Invenso Pharmaceuticals Private Limited
Dheeraj Katyal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Allopath Pharmaceuticals India?
Unlock and access historical data on people associated with Allopath Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allopath Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allopath Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.